Latest news
Jazz Acquires Actio Bioscience | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 18:37:55 GMTJazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 14:22:59 GMTJazz Pharmaceuticals acquires Actio Biosciences, $1.32B deal boosts rare epilepsy portfolio - PharmaLivePharmaLive · Mon, 10 Aug 2026 12:56:54 GMTJazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:30:00 GMTThese Analysts Increase Their Forecasts On Jazz Pharmaceuticals Following Q2 Results - BenzingaBenzinga · Tue, 04 Aug 2026 11:54:52 GMTJazz Pharmaceuticals Announces Second Quarter 2026 Financial Results - PR NewswirePR Newswire · Mon, 03 Aug 2026 20:05:00 GMT